Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ.-Y. Douillard, R. Sidhu, Maria Błasińska-Morawiec et al.|Annals of Oncology|2014Cited by 603